86 results
SC TO-T
EX-99
BMY
Bristol-Myers Squibb Co.
25 Jan 24
Third party tender offer statement
8:13am
“clean team folders” in an electronic data site maintained by or on behalf of the Provider, which Confidential Information shall be made available
DFAN14A
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy materials by non-management
4:36pm
for new option that provides strong efficacy, clean safety and ability to add onto existing medicines Potential first-in-disease treatment for ADP
8-K
EX-10.1
1a9dn9wlyxn3 r3a
6 Nov 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
3chqz nqph
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
8-K
EX-10.2
zky0qdrmhruno7bs
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
425
EX-10.2
bvqtbo
30 Jan 19
Business combination disclosure
4:43pm
425
EX-10.1
igbuwqx4lrqc8e97zuvu
30 Jan 19
Business combination disclosure
4:43pm
8-K
EX-10.1
jnjf61xv nm
22 Jan 19
Entry into a Material Definitive Agreement
4:37pm
425
EX-10.1
slbi jlfsgutksufk
22 Jan 19
Business combination disclosure
4:35pm
8-K
EX-2.1
e9fhh ufqkgjol6
4 Jan 19
Entry into a Material Definitive Agreement
8:52am
425
EX-2.1
e8h lbyzodr484m
4 Jan 19
Business combination disclosure
8:50am